SETD2 mutation Is a recurrent secondary alteration in synovial sarcoma associated with loss of the H3k36me3 histone mark Meeting Abstract


Authors: Tai, H.; Ito, T.; Jungbluth, A.; Ladanyi, M.
Abstract Title: SETD2 mutation Is a recurrent secondary alteration in synovial sarcoma associated with loss of the H3k36me3 histone mark
Meeting Title: 107th Annual Meeting of the United States and Canadian Academy of Pathology (USCAP 2018)
Journal Title: Modern Pathology
Volume: 31
Issue: Suppl. 2
Meeting Dates: 2018 Mar 17-23
Meeting Location: Vancouver, Canada
ISSN: 0893-3952
Publisher: Nature Research  
Date Published: 2018-03-01
Start Page: 38
Language: English
ACCESSION: WOS:000429308600111
PROVIDER: wos
PUBMED: 29551782
DOI: 10.1038/modpathol.2018.2
Notes: Meeting Abstract: 111 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Marc Ladanyi
    1326 Ladanyi
  2. Achim Jungbluth
    454 Jungbluth